Literature DB >> 31655377

Socio-demographic and clinical risk factors of treatment-resistant depression: A Danish population-based cohort study.

Frederikke Hordam Gronemann1, Martin Balslev Jorgensen2, Merete Nordentoft3, Per Kragh Andersen4, Merete Osler5.   

Abstract

BACKGROUND: Knowledge of risk factors of treatment-resistant depression (TRD) contributes to understand the underlying mechanisms and to identify patients at risk. However, there is still a lack of studies on how different risk factors associate with TRD. The objective of this study was to determine the independent association of several socio-demographic and clinical risk factors with TRD.
METHODS: 194.074 patients with a first-time hospital contact for depression identified in the Danish National Patient Registry (DNPR) from 1996 through 2014 were followed for TRD for 12 months after diagnosis. Socio-demographic and clinical risk factors were identified in nation-wide registries. Data were analyzed using Cox Proportional Hazard Regression and Fine-Gray model for competing mortality risk.
RESULTS: Indicators of disease severity (recurrent depression (adjusted HR (aHR) 1.17 (1.14-1.20)), severity of depression (aHR 2.01 (1.95-2.08)), admission to a psychiatric ward (aHR 2.03 (1.96, 2.10)) were strong risk factors. Aged 65-84 (aHR 1.96 (1.83-2.10)), lost labor market affiliation ((aHR 1.12 (1.08, 1.16)), cohabiting (aHR 1.27 (1.23, 1.30)), comorbid anxiety (aHR 1.18 (1.10-1.27)), insomnia (aHR 1.27 (1.06-1.51)), migraine (aHR 1.42 (1.16-1.73)) and use of psychotropic drugs was also associated with higher rates of TRD. LIMITATIONS: Information on drug use during hospitalization was not available. Information on rating scales could have provided a more precise assessment of symptom severity and treatment response.
CONCLUSIONS: Besides indicators of disease severity, other important risk factors associated with TRD are age, lost labor market affiliation, cohabiting with a partner as well as anxiety, insomnia, migraine and the use of psychotropic medications.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressants; Depression; Epidemiology; Major depressive disorder; Population-based study; Treatment-resistant

Mesh:

Substances:

Year:  2019        PMID: 31655377     DOI: 10.1016/j.jad.2019.10.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Treatment-resistant depression and labor market affiliation in the Danish welfare society: a register-based study.

Authors:  Frederikke Hørdam Gronemann; Thomas Lund; Louise Lindholdt; Kathrine Bang Madsen; Martin Balslev Jørgensen; Merete Nordentoft; Merete Osler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-02-08       Impact factor: 4.328

2.  Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study.

Authors:  Heidi Taipale; Johan Reutfors; Antti Tanskanen; Lena Brandt; Jari Tiihonen; Allitia DiBernardo; Ellenor Mittendorfer-Rutz; Philip Brenner
Journal:  BMC Psychiatry       Date:  2020-05-13       Impact factor: 3.630

3.  Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis.

Authors:  Péter Döme; Péter Kunovszki; Péter Takács; László Fehér; Tamás Balázs; Károly Dede; Siobhán Mulhern-Haughey; Sébastien Barbreau; Zoltán Rihmer
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

Review 4.  Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.

Authors:  Alice Caldiroli; Enrico Capuzzi; Ilaria Tagliabue; Martina Capellazzi; Matteo Marcatili; Francesco Mucci; Fabrizia Colmegna; Massimo Clerici; Massimiliano Buoli; Antonios Dakanalis
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

Review 5.  Clinical research challenges posed by difficult-to-treat depression.

Authors:  A John Rush; Harold A Sackeim; Charles R Conway; Mark T Bunker; Steven D Hollon; Koen Demyttenaere; Allan H Young; Scott T Aaronson; Maxine Dibué; Michael E Thase; R Hamish McAllister-Williams
Journal:  Psychol Med       Date:  2022-01-07       Impact factor: 7.723

6.  A comparative study of amplitude of low-frequence fluctuation of resting-state fMRI between the younger and older treatment-resistant depression in adults.

Authors:  Jifei Sun; Chunlei Guo; Yue Ma; Zhongming Du; Zhi Wang; Yi Luo; Limei Chen; Deqiang Gao; Xiaojiao Li; Ke Xu; Yang Hong; Xue Yu; Xue Xiao; Jiliang Fang; Yong Liu
Journal:  Front Neurosci       Date:  2022-08-25       Impact factor: 5.152

7.  Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.

Authors:  Kristoffer Jarlov Jensen; Frederikke Hørdam Gronemann; Mikkel Zöllner Ankarfeldt; Espen Jimenez-Solem; Sarah Alulis; Jesper Riise; Nikolaj Bødker; Merete Osler; Janne Petersen
Journal:  PLoS One       Date:  2022-09-27       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.